Clinical Trial Update: Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy and safety of Ingavirin 60 mg capsules in children with influenza and other acute respiratory viral infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Respiratory Infection

Drugs mentioned

• Ingavirin

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Influenza, Human, Acute Respiratory Infection | Phase 4 | Status: UNKNOWN